Study of Teclistamab in Combination in Elderly Patients With Multiple Myeloma

NCT05572229 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Teclistamab
DRUG: Daratumumab
DRUG: Lenalidomide

Sponsor

University Hospital, Lille

Collaborators

[object Object]